Updated Date: Fri, 08 May 2020 00:00:00 EDT

Updated Date: Fri, 08 May 2020 00:00:00 EDT

Bristol Myers Squibb finally breaks into first-line lung cancer with Opdivo-Yervoy nod chelfand Fri, 05/15/2020 – 16:11

After sneak peak at early data, Operation Warp Speed head Slaoui ‘confident’ in COVID-19 vaccine by year’s end […]

The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with […]

Bristol Myers snags Pomalyst green light in rare AIDS-related skin lesions chelfand Fri, 05/15/2020 – 11:46

Blueprint’s Ayvakit gets FDA no-go in new stomach cancer use but presses ahead in blood disorder aliu Fri, […]

Univercells inks deal to produce prefabricated vaccine facilities for potential COVID-19 shot kblankenship Fri, 05/15/2020 – 10:53

FiercePharmaAsia—Gilead’s remdesivir licensing; Legend’s $100M IPO; Takeda’s blockbuster hopefuls aliu Fri, 05/15/2020 – 07:57

A research team has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein […]